Advertisement
The U.S. Food and Drug Administration has approved Roche's cobas HPV Test as the first diagnostic to be used with cervical cells obtained for a Pap test and collected in SurePath Preservative Fluid.

Approval of First HPV Test for Use With SurePath Preservative Fluid

0
For cervical cells obtained for Pap test, collected in SurePath Preservative Fluid
Medication organization devices may cause medication-related adverse events in unintentionally nonadherent older people

Medication Organization Devices Tied to Adverse Effects

0
Study identifies design elements for future trials to evaluate device effectiveness in elderly
The once-daily acne treatment Differin Gel 0.1% (adapalene) has been approved for over-the-counter use among patients 12 and older

FDA Approves Differin Gel for Over-the-Counter Use

0
First OTC retinoid available for acne treatment among patients 12 and older
An elderly resident of Utah who died at the end of June is the first fatality in the continental United States linked to infection with the Zika virus

Utah Resident Is First Zika-Linked Death in Continental U.S.

0
Patient had an underlying medical condition and tested positive for Zika
Psychosocial factors may be more important than traditional clinical measures in predicting functional disability in the first year after a rheumatoid arthritis diagnosis

Psychosocial Factors Predict Functional Disability in RA

0
Depression, anxiety, missed work, unemployment are predictors of disability at one year
The majority of cancers linked to human papillomavirus are preventable

CDC: Majority of HPV-Linked Cancers Are Preventable

0
Cervical cancer, and oropharyngeal cancers in men, account for most HPV-associated cancers
The U.S. Department of Veterans Affairs is appealing to physicians to join the agency as part of its recovery from a 2014 scandal linked to excessive wait times

VA Appealing to Physicians to Join Agency

0
Key efforts in response to 2014 scandal include reducing wait times, engaging employees
A new study indicates that 8 percent of patients -- or one in 12 -- already diagnosed with one form of cancer will develop a second type of unrelated cancer. The findings were published online  July 5 in Cancer.

Second, Unrelated Malignancies Strike 1 in 12 Cancer Patients

0
Second cancer was fatal in 55 percent of the cases studied
A metabolomics signature can predict the transition from gestational diabetes mellitus to type 2 diabetes

Metabolomics Signature Can Predict GDM to T2DM Transition

0
Metabolomics with baseline fasting plasma could predict transition from gestational diabetes to T2DM
Postpartum readmission rates rose from 2004 to 2011

Postpartum Readmission Within Six Weeks of Delivery on the Rise

0
Readmission more likely among black, publically insured patients with comorbidities